GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Sold by WFA Asset Management Corp

WFA Asset Management Corp lessened its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 31.6% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 487 shares of the company’s stock after selling 225 shares during the quarter. WFA Asset Management Corp’s holdings in GE HealthCare Technologies were worth $44,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Wynn Capital LLC lifted its holdings in GE HealthCare Technologies by 4.1% in the 1st quarter. Wynn Capital LLC now owns 3,125 shares of the company’s stock valued at $284,000 after purchasing an additional 122 shares in the last quarter. Fiduciary Trust Co lifted its holdings in GE HealthCare Technologies by 1.8% in the 4th quarter. Fiduciary Trust Co now owns 7,696 shares of the company’s stock valued at $595,000 after purchasing an additional 133 shares in the last quarter. Janney Capital Management LLC raised its holdings in shares of GE HealthCare Technologies by 4.7% during the 4th quarter. Janney Capital Management LLC now owns 3,289 shares of the company’s stock worth $254,000 after acquiring an additional 149 shares during the period. American National Bank raised its holdings in shares of GE HealthCare Technologies by 25.2% during the 4th quarter. American National Bank now owns 750 shares of the company’s stock worth $58,000 after acquiring an additional 151 shares during the period. Finally, Chilton Capital Management LLC raised its holdings in shares of GE HealthCare Technologies by 15.4% during the 4th quarter. Chilton Capital Management LLC now owns 1,227 shares of the company’s stock worth $95,000 after acquiring an additional 164 shares during the period. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Up 0.9 %

Shares of GE HealthCare Technologies stock traded up $0.70 on Wednesday, reaching $77.03. 696,351 shares of the company were exchanged, compared to its average volume of 3,167,567. GE HealthCare Technologies Inc. has a 1-year low of $62.35 and a 1-year high of $94.50. The company has a market cap of $35.16 billion, a P/E ratio of 22.32, a price-to-earnings-growth ratio of 2.80 and a beta of 1.20. The company has a debt-to-equity ratio of 1.11, a current ratio of 1.06 and a quick ratio of 0.83. The stock’s 50 day moving average price is $79.49 and its 200-day moving average price is $81.86.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Tuesday, April 30th. The company reported $0.90 EPS for the quarter, hitting analysts’ consensus estimates of $0.90. GE HealthCare Technologies had a return on equity of 25.32% and a net margin of 8.05%. The business had revenue of $4.65 billion during the quarter, compared to the consensus estimate of $4.80 billion. During the same period in the previous year, the company posted $0.85 earnings per share. The business’s revenue for the quarter was down 1.2% on a year-over-year basis. As a group, equities analysts forecast that GE HealthCare Technologies Inc. will post 4.27 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Investors of record on Friday, July 19th will be paid a dividend of $0.03 per share. This represents a $0.12 annualized dividend and a yield of 0.16%. The ex-dividend date is Friday, July 19th. GE HealthCare Technologies’s payout ratio is 3.51%.

Insider Buying and Selling

In related news, CTO Taha Kass-Hout sold 3,300 shares of the business’s stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $78.70, for a total transaction of $259,710.00. Following the completion of the sale, the chief technology officer now owns 67,300 shares in the company, valued at $5,296,510. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In related news, CTO Taha Kass-Hout sold 3,300 shares of the business’s stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $78.70, for a total transaction of $259,710.00. Following the completion of the sale, the chief technology officer now owns 67,300 shares in the company, valued at $5,296,510. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Jan Makela sold 20,227 shares of the business’s stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $81.57, for a total value of $1,649,916.39. Following the sale, the chief executive officer now owns 63,348 shares of the company’s stock, valued at approximately $5,167,296.36. The disclosure for this sale can be found here. Insiders sold a total of 90,482 shares of company stock worth $7,369,137 over the last 90 days. 0.27% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several research firms have recently commented on GEHC. The Goldman Sachs Group began coverage on GE HealthCare Technologies in a report on Thursday, May 30th. They set a “neutral” rating and a $87.00 price target on the stock. Citigroup boosted their price objective on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a report on Wednesday, April 3rd. Argus boosted their price objective on shares of GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a report on Monday, April 1st. Bank of America reduced their price objective on shares of GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating on the stock in a report on Wednesday, May 1st. Finally, Mizuho reduced their price objective on shares of GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating on the stock in a report on Wednesday, May 1st. Five research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and an average price target of $94.09.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.